Q32 Bio (QTTB) Stock: Buy, Sell, or Hold?

QTTB - Q32 Bio Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$8.76
0.09 (1.08%) ▲
5d: +12.79%
30d: -8.33%
90d: -42.15%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 12, 2026 20d

Get Alerted When QTTB Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: QTTB is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: QTTB is currently trading at $8.76, which is considered fair relative to its 30-day fair value range of $7.90 to $10.13.

Technical Outlook: Technically, QTTB is in a downtrend. Immediate support is located at $7.28, while resistance sits at $9.15.

Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (19th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $39.67 (+357.5%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $7.90 - $10.13
Company Quality Score 53/100 (HOLD)
Options IV Signal 19th percentile (COMPLACENCY WARNING)
Volume Confirmation HIGH
Confidence Score 80.0%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Options cheap (IV 19th percentile)
  • NEUTRAL: Mixed technical signals (54/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 357.5% below Wall St target ($39.67)
  • WARNING: Composite score 53/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $7.90 - $10.13
Current vs Trading Range FAIR
Expected Move (7 Days) Âą$0.93 (10.7%)

Support & Resistance Levels

Support Level $7.28
Resistance Level $9.16
Current Trend Downtrend
Technical data as of Oct 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) -3.82
Wall Street Target $39.67 (+357.5%)
Profit Margin 62.9%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 22, 2026 12:52 PM ET
Data refreshes hourly during market hours. Next update: 1:52 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for QTTB.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DNLI
Denali Therapeutics Inc
STRONG BUY
20 analysts
$36 68 BUY
SRRK
Scholar Rock Holding Corp
STRONG BUY
18 analysts
$70 71 BUY
WVE
Wave Life Sciences Ltd
STRONG BUY
20 analysts
$17 60 HOLD
MIRM
Mirum Pharmaceuticals Inc
STRONG BUY
14 analysts
$153 68 BUY
RNA
Atrium Therapeutics, Incâ€Ļ
STRONG BUY
15 analysts
$25 62 BUY

More Analysis for QTTB

QTTB Technical Chart QTTB Price Prediction QTTB Earnings Date QTTB Investment Advisor QTTB Fair Price Analyzer QTTB Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals